Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

10:05 ET Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3 Trial

Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC...


08:00 ET Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium

Taiho Oncology, Inc. and Servier today announced clinical data for LONSURF® (trifluridine and tipiracil) for the treatment of patients with...


Jan 19, 2018, 13:37 ET Hollister Ostomy Care Skin Barrier Product Positively Impacts Peristomal Skin Health And Cost Of Care For People With Ostomies

Hollister Incorporated, a global medical device manufacturer, today announced that its ADVOCATE (A Randomized Controlled Trial Determining the...


Jan 19, 2018, 12:06 ET Enzychem Lifesciences announces the FDA Orphan Drug Designation granted to EC-18 on Acute Radiation Syndrome (ARS)

Enzychem Lifesciences, Corp. (KONEX:183490), announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to EC-18...


Jan 19, 2018, 09:06 ET Historic Deal Signed Between Panacea Biotec and Serum Institute of India

Panacea Biotec Ltd. (PBL), India's leading biopharmaceutical company and among the largest manufacturer of vaccines, has signed two long-term...


Jan 19, 2018, 08:30 ET Novel Method of Isolating Infecting Organisms after Joint Replacement

Joint replacement surgery carries the risk of developing an infection in the replaced joint, which can lead to a so-called revision or re-do of the...


Jan 19, 2018, 08:25 ET Oramed Pharmaceuticals' CEO Issues Letter to Shareholders

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com) Dear Shareholders, All the hard work and dedication in 2017 has...


Jan 19, 2018, 08:08 ET Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma

Eisai Inc. announced today results from the independent imaging review (IIR) of the REFLECT study (Study 304), a Phase 3 trial evaluating...


Jan 19, 2018, 08:00 ET Takara Bio USA, Inc. announces the use of the SMARTer™ ICELL8® Single-Cell System in clinical studies

Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that City of...


Jan 19, 2018, 00:01 ET Kaiser Permanente Study Finds Cognitive Behavioral Therapy Is Cost-Effective for Teens Who Decline Antidepressants

Cognitive behavioral therapy (or CBT) delivered in a primary care setting is a cost-effective way to treat adolescents with depression who decline...


Jan 18, 2018, 18:36 ET Impact of the Zika Contraception Access Network (Z-CAN) for Women in Puerto Rico Highlighted in The Lancet Public Health

In 2016 during the Zika virus outbreak, Puerto Rico had the highest number of Zika infections in the United States, a high rate of unintended...


Jan 18, 2018, 18:26 ET Lung Cancer Patients to Help Medical Community Understand the Side Effects of Immunotherapy Treatment

The Lung Cancer Registry sponsored by the Bonnie J. Addario Lung Cancer Foundation (ALCF), the American Lung Association's LUNG FORCE and the...


Jan 18, 2018, 17:15 ET Laminate Medical Technologies announces enrollment of first patients in pivotal trial of the VasQ device

Laminate Medical Technologies (Laminate), a privately-held start-up developing VasQ, an implanted blood vessel external support device for patients...


Jan 18, 2018, 14:47 ET Penn Dental Study Finds Altering Bone Marrow Can Train Innate Immune System

When you receive a vaccine against a disease, your adaptive immune system gears up to defend against that particular infection, a function carried...


Jan 18, 2018, 14:01 ET Study Shows Blood Test Can Detect 8 Types of Cancer

Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test...


Jan 18, 2018, 09:15 ET OncoSec Provides Encouraging Clinical Observations Related To Triple Negative Breast Cancer Study

OncoSec Medical Incorporated ("OncoSec" or the "Company") (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced...


Jan 18, 2018, 08:55 ET BD Announces Completion of Enrollment in the Lutonix™ 014 Drug Coated Balloon Below-The-Knee Trial

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of enrollment in the...


Jan 18, 2018, 08:00 ET Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated phase 1 safety and efficacy data for DS-8201, an...


Jan 18, 2018, 08:00 ET Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated phase 1 safety and efficacy data for DS-8201, an...


Jan 18, 2018, 07:00 ET Compugen Presents New Preclinical Data Demonstrating the Distinctive Features of the PVRIG Pathway in Immuno-Oncology and the Potential of COM701 for Treating Multiple Solid Tumors

Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer...


Jan 18, 2018, 07:00 ET Bluegrass Vascular Announces Enrollment Of First Patients In U.S. Pivotal Trial

Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access,...


Jan 18, 2018, 04:48 ET Add-on en aanspraak voor Eisai's Kisplyx® (lenvatinib) voor de behandeling van gevorderd niercel carcinoom

ALLEEN VOOR NL-MEDIA Eisai BV maakt bekend dat vanaf 1 december 2017 een add-on en aanspraak is toegekend aan Kisplyx® (lenvatinib) in...


Jan 18, 2018, 03:00 ET Biohaven Announces Initiation Of Clinical Development For BHV-5000, A Novel Low-Trapping NMDA Antagonist

Biohaven Pharmaceutical Holding Company Ltd. (Biohaven or the "Company") and its wholly owned subsidiary, Biohaven Pharmaceuticals, Inc., today...


Jan 17, 2018, 19:00 ET GC Pharma Confirms Phase 2/3 Clinical Trial of New Protein Therapy for Hepatitis B

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced that it will proceed...


Jan 17, 2018, 16:09 ET Overall Survival Analysis From KYPROLIS® (Carfilzomib) Phase 3 ASPIRE Trial Published in the Journal of Clinical Oncology

Amgen (NASDAQ:AMGN) today announced that the Journal of Clinical Oncology published positive overall survival (OS) findings from the final analysis...


Most Viewed